Yanzhang Li Selected Research

Non-alcoholic Fatty Liver Disease

1/2021	Epigallocatechin-3-Gallate Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via Inhibition of Apoptosis and Promotion of Autophagy through the ROS/MAPK Signaling Pathway.
1/2020	Hydrogen Sulfide Attenuates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Inhibiting Apoptosis and Promoting Autophagy via Reactive Oxygen Species/Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanzhang Li Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 09/2013
4	Thyroid Neoplasms (Thyroid Cancer) 06/2019 - 03/2018
4	Inflammation (Inflammations) 01/2017 - 01/2011
3	Reperfusion Injury 07/2017 - 01/2015
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 11/2017
2	Fibrosis (Cirrhosis) 01/2016 - 01/2011
2	Ischemia 01/2015 - 03/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 03/2013 - 04/2010
2	Pain (Aches) 10/2004 - 06/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Obesity 11/2021
1	Atherosclerosis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Pathologic Processes 01/2020
1	Ganglion Cysts (Ganglion) 07/2019
1	medullary Thyroid cancer 03/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Wounds and Injuries (Trauma) 07/2017
1	Liver Diseases (Liver Disease) 02/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Leukostasis 01/2015
1	Fatty Liver 01/2015
1	Vascular System Injuries 01/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2015
1	Contusions 03/2013
1	Body Weight (Weight, Body) 04/2011
1	Insulin Resistance 01/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2010
1	Spinal Injuries (Spinal Injury) 04/2010
1	Vascular Diseases (Vascular Disease) 12/2009
1	Neuroblastoma 01/2005

Drug/Important Bio-Agent (IBA)

7	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 06/2019 - 06/2010
5	Peptides (Polypeptides)IBA 06/2019 - 08/2014
4	Retinaldehyde (Retinal)IBA 07/2019 - 01/2015
4	Glucose (Dextrose)FDA LinkGeneric 04/2011 - 12/2009
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2018
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 01/2020
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021 - 01/2019
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 04/2010
2	sodium bisulfide (NaHS)IBA 01/2019 - 11/2017
2	Orphan Nuclear ReceptorsIBA 03/2018 - 01/2018
2	Neuroprotective AgentsIBA 07/2017 - 01/2015
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2017 - 01/2015
2	NF-kappa B (NF-kB)IBA 01/2017 - 01/2016
2	AlbuminsIBA 01/2015 - 06/2010
2	Small Interfering RNA (siRNA)IBA 03/2013 - 04/2010
2	CytokinesIBA 01/2011 - 06/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2004 - 06/2004
1	IronIBA 11/2021
1	Oleic Acid (Oleate)IBA 01/2021
1	amorphous calcium phosphateIBA 01/2021
1	whitlockiteIBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	AntiportersIBA 01/2020
1	Cystine (L-Cystine)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	BenzopyransIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Vascular Endothelial Growth Factor CIBA 06/2019
1	glycyl-glycyl-glycine (triglycine)IBA 06/2019
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 06/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	BromidesIBA 03/2018
1	diphenyl (biphenyl)IBA 03/2018
1	CarbohydratesIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 11/2017
1	Capsaicin (Zostrix)FDA Link 07/2017
1	Thrombospondin 1IBA 02/2017
1	Adenine FDA LinkGeneric 01/2017
1	Mitogen-Activated Protein KinasesIBA 01/2017
1	Periodic AcidIBA 01/2016
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016
1	AntioxidantsIBA 01/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2015
1	Ala-Thr-Trp-Leu-Pro-Pro-ArgIBA 01/2015
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2015
1	OccludinIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 08/2014
1	Cisplatin (Platino)FDA LinkGeneric 09/2013
1	CalpainIBA 03/2013
1	salicylhydroxamic acid (SHAM)IBA 03/2013
1	Cyclic GMP-Dependent Protein Kinase Type IIBA 03/2012
1	AngiotensinsIBA 01/2011
1	Extracellular Matrix ProteinsIBA 06/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2010
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2010
1	Ion Channels (Ion Channel)IBA 01/2005

Therapy/Procedure

4	Therapeutics 11/2021 - 08/2014
1	Photothermal Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Precision Medicine 01/2021
1	Phototherapy (Light Therapy) 01/2021
1	Immunotherapy 01/2020
1	Aftercare (After-Treatment) 01/2019